Literature DB >> 2040704

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

E A Anderson1, R P Hoffman, T W Balon, C A Sinkey, A L Mark.   

Abstract

Hyperinsulinemia may contribute to hypertension by increasing sympathetic activity and vascular resistance. We sought to determine if insulin increases central sympathetic neural outflow and vascular resistance in humans. We recorded muscle sympathetic nerve activity (MSNA; microneurography, peroneal nerve), forearm blood flow (plethysmography), heart rate, and blood pressure in 14 normotensive males during 1-h infusions of low (38 mU/m2/min) and high (76 mU/m2/min) doses of insulin while holding blood glucose constant. Plasma insulin rose from 8 +/- 1 microU/ml during control, to 72 +/- 8 and 144 +/- 13 microU/ml during the low and high insulin doses, respectively, and fell to 15 +/- 6 microU/ml 1 h after insulin infusion was stopped. MSNA, which averaged 21.5 +/- 1.5 bursts/min in control, increased significantly (P less than 0.001) during both the low and high doses of insulin (+/- 5.4 and +/- 9.3 bursts/min, respectively) and further increased during 1-h recovery (+15.2 bursts/min). Plasma norepinephrine levels (119 +/- 19 pg/ml during control) rose during both low (258 +/- 25; P less than 0.02) and high (285 +/- 95; P less than 0.01) doses of insulin and recovery (316 +/- 23; P less than 0.01). Plasma epinephrine levels did not change during insulin infusion. Despite the increased MSNA and plasma norepinephrine, there were significant (P less than 0.001) increases in forearm blood flow and decreases in forearm vascular resistance during both doses of insulin. Systolic pressure did not change significantly during infusion of insulin and diastolic pressure fell approximately 4-5 mmHg (P less than 0.01). This study suggests that acute increases in plasma insulin within the physiological range elevate sympathetic neural outflow but produce forearm vasodilation and do not elevate arterial pressure in normal humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040704      PMCID: PMC296986          DOI: 10.1172/JCI115260

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  The effect of intrahypothalamic injections of glucose on sympathetic efferent firing rate.

Authors:  T Sakaguchi; G A Bray
Journal:  Brain Res Bull       Date:  1987-05       Impact factor: 4.077

3.  Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium.

Authors:  P D'Orléans-Juste; S Dion; J Mizrahi; D Regoli
Journal:  Eur J Pharmacol       Date:  1985-08-07       Impact factor: 4.432

Review 4.  Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis.

Authors:  L Landsberg
Journal:  Q J Med       Date:  1986-12

5.  Resistance to insulin-stimulated-glucose uptake in patients with hypertension.

Authors:  D C Shen; S M Shieh; M M Fuh; D A Wu; Y D Chen; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

6.  Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects.

Authors:  E Bonora; I Zavaroni; O Alpi; A Pezzarossa; F Bruschi; E Dall'Aglio; L Guerra; C Coscelli; U Butturini
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

Review 7.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

8.  Evidence for cholinergically mediated vasodilation at the beginning of isometric exercise in humans.

Authors:  J S Sanders; A L Mark; D W Ferguson
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

Review 9.  Obesity, metabolism, and the sympathetic nervous system.

Authors:  L Landsberg; D R Krieger
Journal:  Am J Hypertens       Date:  1989-03       Impact factor: 2.689

10.  Refined carbohydrate increases blood pressure and catecholamine excretion in SHR and WKY.

Authors:  R D Fournier; C C Chiueh; I J Kopin; J J Knapka; D DiPette; H G Preuss
Journal:  Am J Physiol       Date:  1986-04
View more
  201 in total

1.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Authors:  Z Y Jiang; Y W Lin; A Clemont; E P Feener; K D Hein; M Igarashi; T Yamauchi; M F White; G L King
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

3.  Effects of insulin on adipose tissue blood flow in man.

Authors:  Fredrik Karpe; Barbara A Fielding; Jean-Luc Ardilouze; Vera Ilic; Ian A Macdonald; Keith N Frayn
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

4.  The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

Authors:  C Berne; J Fagius; T Pollare; P Hjemdahl
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

Review 5.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

6.  Contrasting effects of carbohydrate and water on blood pressure responses to postural maneuvers in patients with posturally related (vasovagal) syncope.

Authors:  Marjorie S Pitt; Roger Hainsworth
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

7.  Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.

Authors:  Kamal Rahmouni; Donald A Morgan; Gina M Morgan; Xuebo Liu; Curt D Sigmund; Allyn L Mark; William G Haynes
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 8.  Sodium-retaining effect of insulin in diabetes.

Authors:  Michael W Brands; M Marlina Manhiani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-03       Impact factor: 3.619

Review 9.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 10.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.